Help us deliver products now to those suffering from serious neurological
disorders including autism, epilepsy and schizophrenia.
Eligible donors may take advantage of NeuroNetworks Fund’s 501(C)(3) tax status.
Turning neurodisorder research into marketable products needs to happen faster. NNF focuses on accelerating time to market for much needed drugs, diagnostics and other medical products for patients with serious neurological disorders including autism, epilepsy and schizophrenia. Venture capital and philanthropy are complementary. Each seeks to identify and nurture exciting innovation. Both hope to realize gains in the advancement of medical knowledge. By combining venture capital and philanthropy, NNF aims to close the gap between innovative research that can lead to ground-breaking products and the companies that bring products to market.
Our initial focus on autism, epilepsy and schizophrenia allows us to leverage the new scientific commonality between various conditions once thought to be unrelated. Shared genetic and biochemical pathways give rise to distinctive and potentially overlapping clinical conditions. Basic innovative research is already generating novel insights and innovative technology is waiting to be translated into marketable products. The traditional actors who translate the research into products, the early stage VCs who finance start-up biotechs, are disappearing. As a not-for-profit organization, all investment returns will be reinvested and deployed to support additional projects and novel research to become products that can make a difference.
We identify new therapeutics and diagnostics for patients with serious neurological disorders including autism, epilepsy and schizophrenia.
We invest in companies or form companies that are translating research into products. By bridging the gap between research and product development, we help these companies become attractive to later stage VCs and Pharma who can take them to market.
We work in partnership with both research institutions and commercial organizations.
We are building a network of universities, entrepreneurs, foundations, angel investors, early-stage investors, and pharmaceutical and biotech companies. We work with all stakeholders to meet our goals. To find out more and join our network – click here
Our team and advisors havicone deep biomedical industry knowledge, including bringing scores of drugs and medical products to market, running clinical trials, and founding and growing new businesses.
We are active managers in our investments. We leverage the experience and expertise of our team and advisors to work closely with our investments and to enable their growth and success.
Our investments include traditional product start-ups and platform technology companies, as well as project financing for single assets. We have identified projects ready for investment right now from $250,000 to $5 million. Donate and we can put your money to work right now.
If you’d like to join our network of partners, please contact us.
Scientific Advisory Board (under formation)
Business Advisory Board (under formation)